Widespread antimicrobial use disrupts vital microbial communities that regulate Earth’s biogeochemical cycles, driving antimicrobial resistance, worsening human and environmental health, and significantly contributing to climate change.
|Articles|November 19, 2021
Antibiotics: From Accidental Discovery to Cornerstone of Medicine
Author(s)John Parkinson
From its origins as a serendipitous discovery to being successfully prescribed for nearly a century, antibiotics remain a foundation of medicine. However it has major ongoing challenges including the rise of superbugs and the development of antimicrobial resistance (AMR). There are some prospective strategies to combat AMR on the horizon.
Advertisement
November 18-24 marks both the US Antibiotic Awareness Week and the World Antimicrobial Awareness Week. It cannot be understated that the accidental discovery of penicillin and the subsequent development of antibiotics revolutionized modern medicine. Antibiotics remain a major underpinning within the overall field.
In 1928, Scottish physician-scientist Alexander Fleming began a series of experiments involving the common staphylococcal bacteria. In the fall of that year, Fleming had an uncovered petri dish sitting next to an open window in his lab, which became contaminated with mold spores. He saw that the bacteria in proximity to the mold colonies were dying, as evidenced by the dissolving and clearing of the surrounding agar gel. He was able to isolate the mold and identified it as a member of the Penicillium genus. Hence, the serendipitous discovery of the first antibiotic.1
This class of medicine has been treating patients for nearly a century, yet patients' safety is in danger with the rise of superbugs and antimicrobial resistance. Newer strategies are emerging in hopes of staving off the issue, including
Check out our slideshow on the development of antibiotics, the rise of AMR, and some of the prospective initiatives to combat it.
Reference
1.Tan SY, Tatsumura Y. Alexander Fleming (1881-1955): Discoverer of penicillin. Singapore Med J. 2015;56(7):366-367. doi:10.11622/smedj.2015105
Advertisement
Related to this article
New data from the PETERPEN trial suggest that piperacillin-tazobactam may be noninferior to meropenem for early clinical outcomes in select patients with ESBL bloodstream infections, but carbapenems remain the standard of care until final mortality results are available and fully analyzed.
Outcomes from treating orthopedic infection with debridement and implanted antibiotic were similar whether followed by short or standard duration of systemic antibiotic.
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
New gyrA testing guides ciprofloxacin use for gonorrhea, cutting ceftriaxone reliance while tackling resistance, access, and FDA hurdles.
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
Advertisement
Advertisement
Trending on Contagion Live
1
Measles Update: September 25, 2026
2
US Company Recalls Thousands of Pounds of Uninspected Meat
3
Carbapenem-Sparing Therapy for ESBL Bacteremia: New Trials, Old Questions
4
Enivronmental Stewardship: The Role of Antimicrobials in Climate Change
5